An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study

Yifei Cheng,Lang Wu,Junyi Xin,Shuai Ben,Silu Chen,Huiqin Li,Lingyan Zhao,Meilin Wang,Gong Cheng,Mulong Du
DOI: https://doi.org/10.1186/s12967-024-05190-y
IF: 8.44
2024-04-19
Journal of Translational Medicine
Abstract:Early-onset prostate cancer (EOPC, ≤ 55 years) has a unique clinical entity harboring high genetic risk, but the majority of EOPC patients still substantial opportunity to be early-detected thus suffering an unfavorable prognosis. A refined understanding of age-based polygenic risk score (PRS) for prostate cancer (PCa) would be essential for personalized risk stratification.
medicine, research & experimental
What problem does this paper attempt to address?